| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 472.79 | -306.97 | -287.27 | -341.15 |
| Net Changein Cash | -127.02 | 143.10 | 12.79 | -112.28 |
| Cash Taxes Paid | 8.70 | 7.01 | 0.00 | -10.93 |
| Net Income/ Starting Line | -91.96 | -67.07 | -365.70 | -415.65 |
| Changesin Working Capital | -285.27 | -426.88 | -4.13 | 32.63 |
| Cashfrom Operating Activities | 8.52 | -67.83 | -107.21 | -162.77 |
| Cash Interest Paid | 119.10 | 156.55 | 103.28 | 105.29 |
| Cashfrom Financing Activities | 359.44 | 412.01 | -390.54 | 118.32 |
| Issuance( Retirement)of Stock Net | 5.75 | 875.52 | 0.00 | 564.76 |
| Depreciation/ Depletion | 279.09 | 273.88 | 95.38 | 114.10 |
| Other Investing Cash Flow Items Total | 74.09 | -72.93 | 574.31 | -23.84 |
| Capital Expenditures | -569.07 | -128.15 | -63.77 | -44.00 |
| period Type | - | - | - | - |
| Non- Cash Items | 106.66 | 152.23 | 167.24 | 106.15 |
| Financing Cash Flow Items | -119.10 | -156.55 | -103.28 | -105.29 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -494.98 | -201.08 | 510.54 | -67.83 |
Onesource Specialty Pharma Dividend Onesource Specialty Pharma Bonus Onesource Specialty Pharma News Onesource Specialty Pharma AGM Onesource Specialty Pharma Rights Onesource Specialty Pharma Splits Onesource Specialty Pharma Board Meetings Onesource Specialty Pharma Key Metrics Onesource Specialty Pharma Shareholdings Onesource Specialty Pharma Profit Loss Onesource Specialty Pharma Balance Sheet Onesource Specialty Pharma Q1 Results Onesource Specialty Pharma Q2 Results Onesource Specialty Pharma Q3 Results Onesource Specialty Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.